Emanuela Morelli

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 study.

The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 study.

Journal: Oncoimmunology

Published: June 02, 2025

An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.

An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.

Journal: Annals of hematology

Published: April 18, 2025

Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.

Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.

Journal: European journal of haematology

Published: July 23, 2024

Response to Dr. Ying Cui comments.

Response to Dr. Ying Cui comments.

Journal: Annals of hematology

Published: July 14, 2024

Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study.

Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study.

Journal: British journal of haematology

Published: May 28, 2024

Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura.

Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura.

Journal: Annals of hematology

Published: December 17, 2023

How attachment style, mentalization and preparedness for death are associated with pre-loss grief symptoms' severity: A network analysis study in caregivers of terminally ill cancer patients.

How attachment style, mentalization and preparedness for death are associated with pre-loss grief symptoms' severity: A network analysis study in caregivers of terminally ill cancer patients.

Journal: Death studies

Published: August 11, 2023

Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.

Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.

Journal: Cancers

Published: October 13, 2022

Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab.

Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab.

Journal: Journal of translational medicine

Published: August 21, 2021

Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Journal: Clinical practice and epidemiology in mental health : CP & EMH

Published: March 27, 2021

The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study.

The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study.

Journal: Journal of public health research

Published: March 10, 2021

Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series.

Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series.

Journal: Respiratory research

Published: January 28, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026